[AMGN]

Amgen (AMGN) raised its 2026 guidance ahead of a CFO change, presenting revenue of $382 billion to $394 billion and non‑GAAP EPS of $22.30 to $23.50, a positive development. Based on the upward guidance momentum, I will monitor the trend, but for risk management I will take profit when reaching the profit‑taking target of $398.0 calculated by REPORTING, and I will cut loss if the price falls below the stop‑loss level of $353.95. Considering entry based on the upward guidance announcement, the alignment of moving averages, and an inflow of trading volume at 1.47 times the 20‑day average. The 14‑day RSI stands at 67.6, the moving averages are in a bullish alignment, volume is 1.47 times the 20‑day average, and the price has risen +2.0% over the past seven days, indicating an upward trend and buying‑side momentum. Entering on the basis of a clear fundamental improvement—an upward revision of the 2026 guidance accompanying the CFO change—we achieved a SUCCESS, delivering an actual return of 12.9% versus the expected 15.0%. The entry point featured a bullish moving‑average alignment and a volume increase (1.47× the 20‑day average), while an RSI of 67.6 provided solid momentum to support the uptrend. However, noting that theme‑related news fell from 76 items to 36 (a declining trend), we concluded that the price resilience and gain were driven not by broad‑based large‑cap bio‑theme inflows but by the strong, company‑specific momentum from the upward earnings‑guidance revision. Through this trade, we confirmed that even when overall theme‑related news volume is declining (a falling trend), meaningful performance can be achieved in situations where a clear upward revision of individual companies’ guidance coincides with technical alignment and increased trading volume. Going forward, rather than relying solely on the supply‑demand trend of a theme, we will adhere to the principle of pinpointing entry points by rigorously cross‑checking the consistency of concrete‑number‑backed earnings and guidance releases with technical indicators. Past successful cases such as VEEE (return 451.7%), LRCX (return 346.8%), and AMD (return 338.8%) serve as global top‑performance reference examples, despite lacking direct similarity grounds.

Amgen reported strong performance in the second quarter, leading to an upward revision of its EPS and revenue guidance for 2026. If the stock price continues to break above the upper limit, I will take profits at $398.0, and if the support level breaks down, I will cut losses at $353.95. Despite the stock price showing an upward trend following strong earnings and an upward guidance revision, the current price is approaching the resistance level of $398.00, so it is advisable to carefully assess the potential for a breakout before considering an entry. The RSI(14) is at 67.6, approaching the overbought range, with moving averages in a positive alignment, trading volume at 1.47 times the 20-day average, and a recent 7-day volatility of +2.0%. At the time of the forecast, the stock price was approaching the resistance level of $398.00 with an RSI of 67.6, leading to a cautious observation regarding a potential breakout. However, the actual result showed an overhit, recording a high return of 13.4%, significantly exceeding the anticipated return of 2.0%. The strong performance and upward guidance, which are fundamental positives, were not fully reflected in the trading volume, which was 1.47 times the 20-day average, and the momentum of the moving averages in a bullish arrangement, indicating that the approach was somewhat conservative despite the strong continuation of the trend following the breakout of the resistance level. When the stock price is near a major resistance level, rather than simply being cautious of the difficulty in breaking through, I will flexibly consider the possibility of a significant upward movement if there is strong trend energy, such as trading volume exceeding the 20-day average and the moving averages being in a positive arrangement. Therefore, I will adjust the target price range to be slightly wider from the next trading session.